NCT06865365View on ClinicalTrials.gov

Preoperative Use of Liraglutide Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

February 1, 2027

Study Completion Date

February 1, 2028

Conditions
Obesity, Adolescent
Interventions
DRUG

Liraglutide daily (0.6-3.0mg, highest tolerable dose) additional to dietological measures and lifestyle optimization suggestions

Liraglutide daily (0.6-3.0mg, highest tolerable dose) as additional preoperative method for weight loss

BEHAVIORAL

Dietologic measures and lifestyle optimization for weight loss

all subjects will receive dietary measures and lifestyle opitmization suggestions in order to drop weight preoperatively.

All Listed Sponsors
lead

Medical University of Vienna

OTHER